Cargando…

Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer

BACKGROUND: Bladder cancer is one of the most lethal malignancy in urological system, and 20–25% of bladder cancer patients are muscle invasive with unfavorable prognosis. However, the role of alternative splicing (AS) in muscle-invasive bladder cancer (MIBC) remains to be elucidated. METHODS: Perce...

Descripción completa

Detalles Bibliográficos
Autores principales:	AZhaTi, BaiHeTiYa, Wu, Gaoliang, Zhan, Hailun, Liang, Wei, Song, Zhijian, Lu, Leilei, Xie, Qichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277948/ https://www.ncbi.nlm.nih.gov/pubmed/35820925 http://dx.doi.org/10.1186/s12957-022-02685-0

Ejemplares similares

Up-regulated expression of CD147 gene in malignant bone tumor and the possible induction mechanism during osteoclast formation
por: Qiao, Suchi, et al.
Publicado: (2018)

Up-regulation of DRAM2 promotes tolerance of bladder transitional cell carcinoma to gemcitabine
por: Azhati, Baihetiya, et al.
Publicado: (2020)

Differentiation of Human Adipose Derived Stem Cells into Smooth Muscle Cells Is Modulated by CaMKIIγ
por: Aji, Kaisaier, et al.
Publicado: (2016)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Culture and Identification of Mouse Bone Marrow-Derived Dendritic Cells and Their Capability to Induce T Lymphocyte Proliferation
por: Wang, Wenguang, et al.
Publicado: (2016)

miR-106a-5p Functions as a Tumor Suppressor by Targeting VEGFA in Renal Cell Carcinoma
por: Ma, Jun, et al.
Publicado: (2020)

Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
por: Huang, Runzhi, et al.
Publicado: (2021)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Circular RNA UBAP2 promotes the proliferation of prostate cancer cells via the miR-1244/MAP3K2 axis
por: Li, Xiaodong, et al.
Publicado: (2021)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Diagnosis and Surgical Treatment of Renal Hydatid Disease: a Retrospective Analysis of 30 Cases
por: Rexiati, Mulati, et al.
Publicado: (2014)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance
por: Liu, Chuan, et al.
Publicado: (2020)

Profiling of prognostic alternative splicing in melanoma
por: Ma, Fu-Chao, et al.
Publicado: (2019)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status
por: Dueñas, Marta, et al.
Publicado: (2019)

High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Yang, Long, et al.
Publicado: (2019)

Alternative splicing event associated with immunological features in bladder cancer
por: Yu, Xinbo, et al.
Publicado: (2023)

Alternative splicing events are prognostic in hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Classification of glioma based on prognostic alternative splicing
por: Li, Yaomin, et al.
Publicado: (2019)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma
por: Wan, Qi, et al.
Publicado: (2020)

Diversification of the muscle proteome through alternative splicing
por: Nakka, Kiran, et al.
Publicado: (2018)

Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors
por: Lee, Kyoung-Hwa, et al.
Publicado: (2018)

Corrigendum to “High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer”
por: Yang, Long, et al.
Publicado: (2019)

The effects of alternative splicing on miRNA binding sites in bladder cancer
por: Han, Seonggyun, et al.
Publicado: (2018)

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2022)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
por: Wang, Qian, et al.
Publicado: (2019)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
por: Liang, Weiwei, et al.
Publicado: (2021)

Alternative splicing acts as an independent prognosticator in ovarian carcinoma
por: Ouyang, Yan, et al.
Publicado: (2021)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Competing RNA pairings in complex alternative splicing of a 3′ variable region
por: Pan, Huawei, et al.
Publicado: (2018)

Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
por: Feng, Haoran, et al.
Publicado: (2020)

Characterization, phylogeny, alternative splicing and expression of Sox30 gene
por: Han, Fei, et al.
Publicado: (2010)

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer
por: Wu, Sheng, et al.
Publicado: (2020)

Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
por: Ouyang, Dong, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m2rl09qged98bn1h23tif9eqa5